These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 27904939)

  • 1. [Time interval between neoadjuvant radiochemotherapy and surgery in rectal cancer : No impact on the pathologic complete response rate?].
    Gani C; Zips D
    Strahlenther Onkol; 2017 Jan; 193(1):91-92. PubMed ID: 27904939
    [No Abstract]   [Full Text] [Related]  

  • 2. Impact of interval between neoadjuvant chemoradiotherapy and TME for locally advanced rectal cancer on pathologic response and oncologic outcome.
    Wolthuis AM; Penninckx F; Haustermans K; De Hertogh G; Fieuws S; Van Cutsem E; D'Hoore A
    Ann Surg Oncol; 2012 Sep; 19(9):2833-41. PubMed ID: 22451236
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of interval between neoadjuvant chemoradiotherapy and surgery for rectal cancer on surgical and oncologic outcome.
    Zeng WG; Zhou ZX; Liang JW; Wang Z; Hou HR; Zhou HT; Zhang XM; Hu JJ
    J Surg Oncol; 2014 Sep; 110(4):463-7. PubMed ID: 24889826
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathological complete response and sphincter-sparing surgery after neoadjuvant radiochemotherapy with regional hyperthermia for locally advanced rectal cancer compared with radiochemotherapy alone.
    Schroeder C; Gani C; Lamprecht U; von Weyhern CH; Weinmann M; Bamberg M; Berger B
    Int J Hyperthermia; 2012; 28(8):707-14. PubMed ID: 23006132
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimal Timing to Surgery after Neoadjuvant Chemoradiotherapy for Locally Advanced Rectal Cancer.
    Sun Z; Adam MA; Kim J; Shenoi M; Migaly J; Mantyh CR
    J Am Coll Surg; 2016 Apr; 222(4):367-74. PubMed ID: 26897480
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Predictive factors associated with pathologic complete response after neoadjuvant chemoradiotherapy in rectal cancer].
    Sun Y; Chi P; Xu B; Lin H; Lu X; Huang Y; Xu Z; Huang S; Jiang C
    Zhonghua Wei Chang Wai Ke Za Zhi; 2014 Jun; 17(6):556-60. PubMed ID: 24953361
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Prediction of efficacy of neoadjuvant radiochemotherapy based on depth of invasion in T3 rectal cancer].
    Shen L; Tong T; Zhang H; Sun Y; Zhu J; Cai G; Li G; Liang L; Cai X; Fan M; Huang J; Yang L; Sun W; Cai S; Zhang Z
    Zhonghua Wei Chang Wai Ke Za Zhi; 2014 Jun; 17(6):551-5. PubMed ID: 24953360
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Will radiotherapy be used on more or fewer patients with rectal cancer?].
    Glimelius B; Påhlman L; Holm T; Blomqvist L
    Lakartidningen; 2014 Jul 2-15; 111(27-28):1180-2. PubMed ID: 25162107
    [No Abstract]   [Full Text] [Related]  

  • 9. Statin therapy is associated with improved pathologic response to neoadjuvant chemoradiation in rectal cancer.
    Mace AG; Gantt GA; Skacel M; Pai R; Hammel JP; Kalady MF
    Dis Colon Rectum; 2013 Nov; 56(11):1217-27. PubMed ID: 24104995
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optimal time interval between neoadjuvant chemoradiotherapy and surgery for rectal cancer.
    Sloothaak DA; Geijsen DE; van Leersum NJ; Punt CJ; Buskens CJ; Bemelman WA; Tanis PJ;
    Br J Surg; 2013 Jun; 100(7):933-9. PubMed ID: 23536485
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Research progress on pathologic complete response after neoadjuvant chemoradiotherapy for locally advanced rectal cancer].
    Peng HH; You KY; Gao YH; Wen BX
    Zhonghua Wei Chang Wai Ke Za Zhi; 2013 Jun; 16(6):592-6. PubMed ID: 23801217
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Why is neoadjuvant chemoradiation therapy underused for locally advanced rectal cancer?
    Molinari C; Passardi A
    Expert Rev Gastroenterol Hepatol; 2016 Dec; 10(12):1317-1319. PubMed ID: 27754713
    [No Abstract]   [Full Text] [Related]  

  • 13. CEA - a predictor for pathologic complete response after neoadjuvant therapy for rectal cancer.
    Wallin U; Rothenberger D; Lowry A; Luepker R; Mellgren A
    Dis Colon Rectum; 2013 Jul; 56(7):859-68. PubMed ID: 23739192
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of long interval between hyperthermochemoradiation therapy and surgery for rectal cancer on apoptosis, proliferation and tumor response.
    Kato T; Fujii T; Ide M; Takada T; Sutoh T; Morita H; Yajima R; Yamaguchi S; Tsutsumi S; Asao T; Oyama T; Kuwano H
    Anticancer Res; 2014 Jun; 34(6):3141-6. PubMed ID: 24922685
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Does residual microscopic disease after chemoradiotherapy for locally advanced rectal cancer translate into a good clinical outcome?
    Geva R; Davidovics H; Soyfer S; Pelles-Avraham S; Klausner JM; Inbar M; Tulchinsky H
    Colorectal Dis; 2017 Mar; 19(3):237-242. PubMed ID: 27474791
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Significance of acellular mucin pools in rectal carcinoma after neoadjuvant chemoradiotherapy.
    Shia J; McManus M; Guillem JG; Leibold T; Zhou Q; Tang LH; Riedel ER; Weiser MR; Paty PB; Temple LK; Nash G; Kolosov K; Minsky BD; Wong WD; Klimstra DS
    Am J Surg Pathol; 2011 Jan; 35(1):127-34. PubMed ID: 21164296
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increasing the Interval Between Neoadjuvant Chemoradiotherapy and Surgery in Rectal Cancer.
    Lefevre JH; Parc Y; Tiret E;
    Ann Surg; 2015 Dec; 262(6):e116. PubMed ID: 24887983
    [No Abstract]   [Full Text] [Related]  

  • 18. Clinical outcome of neoadjuvant chemoradiation in locally advanced rectal cancer at a tertiary hospital.
    Yeung WW; Ma BB; Lee JF; Ng SS; Cheung MH; Ho WM; Tsang MW; Chu S; Lam DC; Mo FK
    Hong Kong Med J; 2016 Dec; 22(6):546-55. PubMed ID: 27795447
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neoadjuvant chemoradiotherapy with capecitabine followed by laparoscopic resection in locally advanced tumors of middle and low rectum - toxicity and complications of the treatment.
    Soumarova R; Skrovina M; Bartos J; Gruna J; Wendrinski A; Czudek S; Kycina R; Parvez J
    Eur J Surg Oncol; 2010 Mar; 36(3):251-6. PubMed ID: 19879716
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rectal cancer: assessment of response to neoadjuvant chemoradiation by dynamic contrast-enhanced MRI.
    Oberholzer K; Menig M; Pohlmann A; Junginger T; Heintz A; Kreft A; Hansen T; Schneider A; Lollert A; Schmidberger H; Christoph D
    J Magn Reson Imaging; 2013 Jul; 38(1):119-26. PubMed ID: 23188618
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.